Across TCGA pan-cancer cohorts, SNORA70I RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of SNORA70I’s most consistent transcriptional readouts.

The strongest signal is observed in breast invasive carcinoma (BRCA), where SNORA70I RNA is more highly expressed in tumor relative to normal tissue. In most cancer types SNORA70I is over-expressed in tumor.

BRCA, LUAD, and STAD are the cancer types where SNORA70I tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in SNORA70I RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BRCA	All	All	+0.073	.020	2	view →
LUAD	All	All	+0.169	.043	1	view →
STAD	All	II,III,IV	+0.091	.048	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

Exploration

Same gene, other analysis: SNORA70I RNA expression & survival · all SNORA70I data types